Liver Tumors and Liver Cancer

Complete English Translation · Source 1

Chengdu Puji Traditional Chinese Medicine Research Institute

Chengdu Puji TRADITIONAL CHINESE MEDICINE RESEARCH INSTITUTE Traditional Chinese Medicine Outpatient Department

Chengdu Puji

Traditional Chinese Medicine Case of Tumor Rehabilitation

Kindness and skillfulness

Differentiate treatment according to symptoms and treat both root and symptoms; live with tumor

Clinical summary:

Disease: hepatocellular carcinoma, Age: 61, Gender: male, Region: Heilongjiang

Qiqihar, Heilongjiang Province, 61-year-old patient with hepatocellular carcinoma [PATIENT], previously received Western medicine treatment locally, 4

Symptoms; due to perceived poor effectiveness, visited our hospital in May;

in the month, the disease worsened, with a large tumor in the left lobe of the liver reaching 11.4cm 8.9cm×12cm, and ascites appeared

Tianjin Cancer Hospital Medical Imaging Diagnostic Report

Clinical diagnosis

Visit date

2024-07-06 08:28:28

Age: 61

Patient name: [REDACTED]

Applying department: Hepatobiliary Tumor Department

Gender: male

MRI examination

| Examination name

Bed number: [REDACTED]

Patient ID: P[ID REDACTED] Admission number: [REDACTED]

Examination number: [REDACTED]

[ID REDACTED]

Examination date: 2024/4/16

MRI non-contrast + enhancement (general)

| Examination item

Clinical judgment: malignant hepatic tumor

Examination items: upper abdomen MRI non-contrast + enhancement (general), upper abdomen MRI non-contrast

[unclear in source]Imaging findings

imaging findings:

scan (conventional),

smooth, wavy, rounded at the inferior hepatic margin; abnormal signal visible in the left hepatic lobe,

"multiple percutaneous transhepatic hepatic artery embolization post-op", hepatic margin not

"multiple percutaneous transhepatic hepatic artery embolization post-op", right hepatic lobe,

signal, slightly hyperintense on fat-suppressed T2WI,

irregular abnormal signal at the margin, slightly hypointense on T1W,

and DWI signals are mixed,

mass lesion, slightly hypointense to slightly hyperintense on T1WI, fat-suppressed T2WI signal

inhomogeneous enhancement on enhanced scanning,

size approximately 2.2cmx1.5cm. Hepatic,

DWI shows slightly hyperintense signal,

contrast agent flow visible in the portal and delayed phases, with delayed enhancement at the margins,

enhanced scanning shows inhomogeneous arterial phase enhancement, portal

signal, fat-suppressed T2WI and DWI signals are mixed, enhanced scanning,

abnormal signal mass lesion visible in the left lobe,

slightly hypointense to slightly hyperintense,

size approximately 11.3x8.8x10.8cm,

additional multiple abnormal signal nodules are seen, slightly hypointense on T1WI,

F left venous is not clearly displayed; hepatic,

shows uneven enhancement in the arterial phase,

agent flow out, with delayed enhancement at the margins, size approximately

contrast agent flow visible in the portal and delayed phases,

shows uneven enhancement in the arterial phase, contrast agent flow visible in the portal and delayed phases,

slightly hyperintense on fat-suppressed T2WI, slightly hyperintense on DWI, enhanced scanning,

11.4x8.9x12.0cm,

additional multiple abnormal signal nodules, slightly hypointense on T1WI,

the left hepatic venous is not clearly displayed; intrahepatic,

scanned shows uneven enhancement in the arterial phase, contrast agent flow visible in the portal and delayed phases,

fat-suppressed T2WI shows slightly hyperintense signal,

DWI shows slightly hyperintense signal, with enhancement

appears, part of the margins show delayed enhancement, the larger lesion located in the right posterior hepatic lobe

margin, size approximately 1.6cmx1.2cm; hepatic parenchyma signal is rough and

contrast agent leakage, part of the margins show delayed enhancement; the larger lesion located at

reticulate appearance, with multiple slightly short T1 and slightly long T2 signals, with strong

located at the edge of the right posterior hepatic lobe, size approximately 1.7cmx1.3cm, hepatic solid

changes; another non-enhancing long T1 and long T2 signal shadow seen within the liver; intra- and extrahepatic

signal, with enhancement seen; another non-enhancing long T1 and long T2

rough texture, reticulate appearance, multiple slightly short T1 and slightly long T2

biliary ducts show no dilation. Gallbladder size is normal, thin wall, no abnormal signal shadows seen inside

normal, thin wall, no abnormal signal shadows seen inside. Pancreas course

signal shadows; no dilation seen in intra- and extrahepatic biliary ducts. Gallbladder size is normal

abnormal signal shadows. Pancreas course is natural, no dilation of pancreatic duct. Spleen

large, homogeneous signal in the parenchyma, splenic peri-lesion, signal and enhancement similar to spleen.

splenic peri-lesion, signal and enhancement are similar to spleen. Left kidney shows no enhancement

natural, no dilation of pancreatic duct. Splenomegaly, homogeneous signal in the parenchyma,

Left kidney shows no enhancement, long T1 and long T2 signal shadows; right kidney and both adrenal glands

normal. No obvious enlarged lymph nodes seen in the retroperitoneum, no abnormalities seen in the peritoneal cavity

long T1 and long T2 signal shadows, no abnormalities seen in the right kidney and both adrenal glands

effusion.

Adrenal glands show no abnormalities. No obvious enlarged lymph nodes are seen in the retroperitoneum; peritoneal cavity

effusion.

After one month of medication, upon July follow-up, the tumor size decreased to 11.3cm ×8.8cm ×10.8cm

; thereafter, intermittent medication for a total of three and a half months, each time follow-up shows tumor shrinkage, report from November check

The tumor size has decreased to 10.1cm×8.1cm×9.4cm.

Medical Imaging Diagnostic Report from Tianjin Tumor Hospital

Medical Imaging Diagnostic Report from Tianjin Tumor Hospital

Patient name: [REDACTED]

age: 61

gender: male

internal medicine department

requesting department: hepatobiliary tumor

age: 61

patient name: [REDACTED]

gender: male

requesting department: hepatobiliary tumor

patient ID: P[ID REDACTED] previous hospital admission number: 740054

patient ID: P[ID REDACTED] admission number: [REDACTED]

internal medicine

Examination number: [REDACTED]

bed number: [REDACTED] 0

[ID REDACTED]

examination date: 2024/9/13

Examination number: [REDACTED]

bed number: [REDACTED]

[ID REDACTED]

2024/11/22

examination date:

clinical assessment: hepatocellular carcinoma

clinical assessment: hepatocellular carcinoma

examination item: upper abdominal MRI plain scan + contrast enhancement (general), upper abdominal MRI

imaging findings:

plain scan (general)

examination item: upper abdominal MRI plain scan + contrast enhancement (general), upper abdominal MRI

imaging findings:

plain scan (general) drug 0)

irregular and wavy, lower liver margin rounded; left lobe of liver may

following multiple percutaneous transhepatic arterial embolization procedures, the liver margin

irregular and wavy, lower liver margin rounded; left lobe of liver may

"multiple percutaneous transhepatic arterial embolization postoperatively," hepatic margin

fat-suppressed T2WI signal and DWI signal are mixed, enhanced scanning arterial phase

abnormal signal mass detected, T1WI shows slightly hypointense to slightly hyperintense signal,

fat-suppressed T2W/ signal and DW/ signal are mixed, enhanced scanning arterial phase

abnormal signal mass detected, slightly hypointense to slightly hyperintense on T1WI,

contrast agent leakage, margin shows delayed enhancement, size about

inhomogeneous enhancement during the arterial phase,

contrast agent visible during the portal and delayed phases,

inhomogeneous enhancement during the arterial phase, contrast agent visible during the portal and delayed phases,

contrast agent leakage, margin shows delayed enhancement, size about

10.5x8.3x10.5cm,

intratumoral lesions with multiple abnormal signal foci, slightly hypointense on T1WI,

left hepatic vein not clearly visualized; hepatic

in addition, multiple abnormal signal foci detected, slightly hypointense on T1W

left hepatic vein not clearly visualized; intrahepatic

number, slightly hyperintense on fat-suppressed T2WI, slightly hyperintense on DWI,

number, uneven enhancement during the arterial phase,

number, slightly hyperintense on fat-suppressed T2WI, slightly hyperintense on DWI,

number, uneven enhancement during the arterial phase, visible during the portal and delayed phases,

delayed phase shows contrast agent leakage,

part of the margin shows strong delayed enhancement,

portal and delayed phases,

enhancement, the larger lesion located at the periphery of the right posterior hepatic lobe, size about

delayed phase shows contrast agent leakage,

part of the margin shows strong delayed enhancement,

1.9cmx1.5cm; hepatic parenchyma shows rough signal with a mesh-like appearance,

enhancement, the larger lesion located at the periphery of the right posterior hepatic lobe, size about

1.9cmx1.5cm; hepatic parenchyma shows rough signal with a mesh-like appearance,

in addition, non-enhancing long T1 long T2 signal foci detected; intra- and extra-hepatic biliary

multiple slightly short T1 and slightly long T2 signal foci visible, with enhancement; hepatic

Another area shows non-enhancing long T1 long T2 signal: intra- and extra-hepatic biliary

Multiple slightly short T1 slightly long T2 signals visible, with enhancement; liver

No abnormal signal detected. Pancreas has natural course,

bile ducts not dilated.

gallbladder size is normal, wall not thickened, and within

No abnormal signal detected. Pancreas has natural course,

bile ducts not dilated. Gallbladder size is normal, wall not thickened, and within

dilated. Splenomegaly; uniform in substance signal, splenic peri-nodal lesions,

bile ducts not seen

dilated. Splenomegaly, uniform in substance signal, splenic peri-nodal lesions, signal

bile ducts not seen

number and enhancement similar to spleen. Left kidney shows non-enhancing long T1 long T2 signal

signal

number and enhancement similar to spleen. Left kidney shows non-enhancing long T1 long T2 signal

number shadow, no abnormalities seen in right kidney and both adrenal glands. Post-peritoneal

number shadow, no abnormalities seen in right kidney and both adrenal glands. Post-peritoneal

No clearly enlarged lymph nodes observed,

inconsistent, peritoneum slightly thickened, uneven enhancement, and peritoneal fluid.

signal in the intermesenteric fat layer

inconsistent, peritoneum slightly thickened, uneven enhancement, and small peritoneal fluid.

No clearly enlarged lymph nodes observed; signal in the intermesenteric fat layer

fluid.